Wall Drugs offered an incentive stock option plan to its employees. On January 1, 2021, options were granted for 63.000 $1 par common shares. The exercise price equals the $5 market price of the common stock on the grant date. The options cannot be exercised before January 1, 2024, and expire December 31, 2025. Each option has a fair value of $1 based on an option pricing model. Which is the correct entry to record the exercise of 90% the options on April 15, 2024, when the market price of the stock was $8? Multiple Choice Paid-in capital-stock options Common stock Paid-in capital-excess of par 1283.500l 56,700 63,000 277,200 0 56,700 Paid-in capital-stock options Common stock Paid-in capital excess of par 0 Paid-in capital-excess of La capital-stock optione 3 Pald-in ealtai-toek option 2,500 was $8? Multiple Choice Cash Paid-in capital-stock options Common stock Paid-in capital-excess of par 283,500 56,700 63,000 1277, 200 Cash Paid-in capital-stock options Common stock Paid-in capital-excess of par 396,900 56, 700 56,700 396,900 Cash Paid-in capital-stock options Compensation expense Common stock Paid-in capital-excess of par 283,500 56,700 113,4001 56,700 396,900 Cash Paid-in capital-stock options Common stock Paid-in capital-excess of par 283,500 56,700 56,700 283,500